Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DL-3-n-butylphthalide for Mild Vascular Dementia Caused by SIVD
NCT03906123Unknown
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Nov 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of butylphthalide in vascular dementia (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Auditory Verbal Learning Test at 48 weeks, Brief Visuospatial Memory Test-Revised at 48 weeks and 11 more. Status: unknown.
02
Drugs
butylphthalide
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT03906123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03906123.